journal article·2019-11

DNA aptamer immobilized hydroxyapatite for enhancing angiogenesis and bone regeneration

Jaewoo Son, Junhyung Kim, Kyungwoo Lee, Jangsun Hwang, Yonghyun Choi, Youngmin Seo, Hojeong Jeon, Ho Chang Kang, Heung-Myung Woo, Byung-Jae Kang, Jonghoon Choi

Acta Biomaterialia· Volume 99
Publisher page

Abstract

In this study, we developed aptamer-conjugated hydroxyapatite (Apt-HA) that promotes bone regeneration and angiogenesis. The 3R02 bivalent aptamer specific to vascular endothelial growth factor (VEGF) was grafted to the hydroxyapatite (HA) surface. Apt-HA was tested for its VEGF protein capture ability to determine the optimal aptamer concentration immobilized on the HA. Apt-HA showed higher VEGF protein capture ability, and faster growth of human umbilical vein endothelial cell (HUVEC) compared to a neat HA with no cytotoxic effects on human osteoblasts. To examine in vivo angiogenesis and bone regeneration, Apt-HA and HA were bilaterally implanted into rabbit tibial metaphyseal defects and analyzed after eight weeks using micro-CT, histology, and histomorphometry. Apt-HA showed significantly increased the volume of new bones, the percentage of bone, and the density of bone mineral in cortical bone. Apt-HA also exhibited the enhanced bone formation at the cortical region in a histomorphometric analysis. Finally, Apt-HA showed significantly increased blood vessel number compared to a neat HA. In summary, the engineered Apt-HA has potential as a bone graft material that may simultaneously promote bone regeneration and angiogenesis. STATEMENT OF SIGNIFICANCE: This work presents a functional hydroxyapatite bone graft using a DNA-based aptamer which overcomes the limitations of existing bone graft materials, which use bound signaling peptides. DNA aptamer immobilized hydroxyapatite enhances the in vitro proliferation of human umbilical vascular endothelial cells as well as in vivo angiogenesis and bone regeneration. DNA aptamer immobilized hydroxyapatite shows no cytotoxic effect on human osteoblasts.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Hydroxyapatite as a bone substitute10.7547/87507315-89-8-392 ↗
2. Hydroxyapatite and their use as coatings in dental implants: a review
3. Functional hydroxyapatite bioceramics with excellent osteoconductivity and stern-interface induced antibacterial ability10.1039/C6BM00009F ↗
4. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines10.1002/jcp.20988 ↗
5. Osteoblasts and bone formation
6. Angiogenesis in bone regeneration10.1016/j.injury.2011.03.035 ↗
7. Osteoinductivity assessment of BMP-2 loaded composite chitosan-nano-hydroxyapatite scaffolds in a rat muscle pouch10.3390/ma4081360 ↗
8. BMP-2 tethered hydroxyapatite for bone tissue regeneration: coating chemistry and osteoblast attachment10.1002/jbm.a.34241 ↗
9. Bmp-2 modified hydroxyapatite/chitosan composite scaffold for bone engineering
10. Protein denaturation10.1016/S0065-3233(08)60401-5 ↗
11. On the pH dependence of protein stability10.1006/jmbi.1993.1294 ↗
12. In vitro selection of RNA molecules that bind specific ligands10.1038/346818a0 ↗
13. Aptamers as theranostic agents: modifications, serum stability and functionalisation10.3390/s131013624 ↗
14. Aptamers as therapeutics10.1038/nrd3141 ↗
15. Hierarchically nanostructured hydroxyapatite: hydrothermal synthesis, morphology control, growth mechanism, and biological activity10.2147/IJN.S29884 ↗
16. Synthesis and characterization of hydroxyapatite nanoparticles and β-TCP particles
17. Socrates · 2004
18. Kim · 2011
19. Surface charge and the effect of excess calcium ions on the hydroxyapatite surface10.1016/j.biomaterials.2005.04.060 ↗
20. Hydroxyapatite-mediated separation of double-stranded DNA, single-stranded DNA, and RNA genomes from natural viral assemblages10.1128/AEM.00204-10 ↗
21. DNA adsorbed on hydroxyapatite surfaces10.1039/C4TB01184H ↗
22. DNA binding to hydroxyapatite: a potential mechanism for preservation of microbial DNA10.1016/j.joen.2012.09.013 ↗
23. Detection of Yersinia pestis DNA in two early medieval skeletal finds from Aschheim (Upper Bavaria, 6th century AD)10.1002/ajpa.10276 ↗
24. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer10.1016/S0959-8049(98)00282-2 ↗
25. VEGF and endostatin levels in wound fluid and plasma after breast surgery10.1023/B:AGEN.0000029410.32264.b0 ↗
26. Osteoclastic resorption of calcium phosphate ceramics with different hydroxyapatite/β-tricalcium phosphate ratios10.1016/S0142-9612(97)00036-7 ↗
27. Molecular dynamics simulations of the adsorption of amino acids on the hydroxyapatite {100}-water interface10.1007/s11706-008-0046-0 ↗
28. VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors10.1160/TH03-02-0084 ↗
29. Vascular endothelial growth factor–induced endothelial cell migration and proliferation depend on a nitric oxide–mediated decrease in protein kinase Cδ activity10.1161/01.RES.85.3.247 ↗
30. Vasostatin inhibits VEGF-induced endothelial cell proliferation, tube formation and induces cell apoptosis under oxygen deprivation10.3390/ijms15046019 ↗
31. In vitro cytotoxicity evaluation of biomaterials on human osteoblast cells CRL-1543; hydroxyapatite, natural coral and polyhydroxybutarate
32. VEGF-activated angiogenesis during bone regeneration10.1016/j.joms.2005.05.303 ↗
33. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration10.1016/j.biomaterials.2006.01.033 ↗
34. Effect of hydroxyapatite on bone integration in a rabbit tibial defect model10.4055/cios.2010.2.2.90 ↗
35. Bone response to hydroxyapatite particles of different shapes in rabbit tibia10.1016/0278-2391(90)90292-A ↗
36. In vivo evaluation of resorbable bone graft substitutes in a rabbit tibial defect model10.1016/j.biomaterials.2004.02.014 ↗
37. Resorbable and nonresorbable hydroxyapatite granules as bone graft substitutes in rabbit cortical defects10.1111/j.1708-8208.2003.tb00190.x ↗
38. Controlled release of vascular endothelial growth factor from spray-dried alginate microparticles in collagen–hydroxyapatite scaffolds for promoting vascularization and bone repair10.1002/term.2013 ↗
39. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover10.1073/pnas.152324099 ↗
40. VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo
41. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model10.1016/j.bone.2008.06.019 ↗
42. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model10.1089/ten.tea.2008.0510 ↗
43. In vivo osteogenic response to different ratios of BMP-2 and VEGF released from a biodegradable porous system10.1002/jbm.a.34183 ↗
44. A differential effect of bone morphogenetic protein-2 and vascular endothelial growth factor release timing on osteogenesis at ectopic and orthotopic sites in a large-animal model10.1089/ten.tea.2011.0560 ↗
45. Local controlled release of VEGF and PDGF from a combined brushite–chitosan system enhances bone regeneration10.1016/j.jconrel.2009.11.026 ↗
46. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration10.1016/j.biomaterials.2009.01.031 ↗
47. Affinity improvement of a VEGF aptamer by in silico maturation for a sensitive VEGF-detection system10.1021/ac303023d ↗
48. Aminopropyltriethoxysilane-mediated surface functionalization of hydroxyapatite nanoparticles: synthesis, characterization, and in vitro toxicity assay
49. Structure of 3-aminopropyl triethoxy silane on silicon oxide10.1016/0021-9797(91)90139-Y ↗
50. A practical approach to crosslinking10.1007/BF00986726 ↗
51. E. ISO, 10993-12: 2008–Biological evaluation of medical devices–Part 12: Sample preparation and reference materials (ISO 10993-12: 2007), German version: DIN EN ISO (2008) 10993-10912.